aluates Reports

$ 0.0

Automative

Global Gram-positive Bacterial Infection Drugs Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-34I942

Global Gram positive Bacterial Infection Drugs Market Insights and Forecast to 2028

BUY CHAPTERS

Global Gram-positive Bacterial Infection Drugs Market Research Report 2025

Code: QYRE-Auto-34I942

Report

September 2025

Pages:76

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

Sanofi

GlaxoSmithKline PLC

Bayer

Bristol–Myers Squibb

Novartis

Merck

Astrazeneca plc

Allergan plc

Theravance Biopharma

Gram-positive Bacterial Infection Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Gram-positive Bacterial Infection Drugs Market

The global market for Gram-positive Bacterial Infection Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Gram-positive bacteria are those that are stained dark blue or violet by Gram staining. They are a major class of bacteria that cause various infections in humans.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Gram-positive Bacterial Infection Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gram-positive Bacterial Infection Drugs.

The Gram-positive Bacterial Infection Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gram-positive Bacterial Infection Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Gram-positive Bacterial Infection Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Gram-positive Bacterial Infection Drugs Market Report

Report Metric	Details
Report Name	Gram-positive Bacterial Infection Drugs Market
CAGR	5%
Segment by Type	Antibiotic Antifungal Others
Segment by Application	Hospital Pharmacies Retail Pharmacies Online Pharmacies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Sanofi, GlaxoSmithKline, Bayer, Bristol-Myers Squibb, Novartis, Merck, AstraZeneca, Allergan, Theravance Biopharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gram-positive Bacterial Infection Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Gram-positive Bacterial Infection Drugs Market report?

Ans: The main players in the Gram-positive Bacterial Infection Drugs Market are Pfizer, Sanofi, GlaxoSmithKline, Bayer, Bristol-Myers Squibb, Novartis, Merck, AstraZeneca, Allergan, Theravance Biopharma

What are the Application segmentation covered in the Gram-positive Bacterial Infection Drugs Market report?

Ans: The Applications covered in the Gram-positive Bacterial Infection Drugs Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Gram-positive Bacterial Infection Drugs Market report?

Ans: The Types covered in the Gram-positive Bacterial Infection Drugs Market report are Antibiotic, Antifungal, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Gram-positive Bacterial Infection Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Antibiotic

1.2.3 Antifungal

1.2.4 Others

1.3 Market by Application

1.3.1 Global Gram-positive Bacterial Infection Drugs Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Gram-positive Bacterial Infection Drugs Market Perspective (2020-2031)

2.2 Global Gram-positive Bacterial Infection Drugs Growth Trends by Region

2.2.1 Global Gram-positive Bacterial Infection Drugs Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Gram-positive Bacterial Infection Drugs Historic Market Size by Region (2020-2025)

2.2.3 Gram-positive Bacterial Infection Drugs Forecasted Market Size by Region (2026-2031)

2.3 Gram-positive Bacterial Infection Drugs Market Dynamics

2.3.1 Gram-positive Bacterial Infection Drugs Industry Trends

2.3.2 Gram-positive Bacterial Infection Drugs Market Drivers

2.3.3 Gram-positive Bacterial Infection Drugs Market Challenges

2.3.4 Gram-positive Bacterial Infection Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Gram-positive Bacterial Infection Drugs Players by Revenue

3.1.1 Global Top Gram-positive Bacterial Infection Drugs Players by Revenue (2020-2025)

3.1.2 Global Gram-positive Bacterial Infection Drugs Revenue Market Share by Players (2020-2025)

3.2 Global Gram-positive Bacterial Infection Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Gram-positive Bacterial Infection Drugs Revenue

3.4 Global Gram-positive Bacterial Infection Drugs Market Concentration Ratio

3.4.1 Global Gram-positive Bacterial Infection Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Gram-positive Bacterial Infection Drugs Revenue in 2024

3.5 Global Key Players of Gram-positive Bacterial Infection Drugs Head office and Area Served

3.6 Global Key Players of Gram-positive Bacterial Infection Drugs, Product and Application

3.7 Global Key Players of Gram-positive Bacterial Infection Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Gram-positive Bacterial Infection Drugs Breakdown Data by Type

4.1 Global Gram-positive Bacterial Infection Drugs Historic Market Size by Type (2020-2025)

4.2 Global Gram-positive Bacterial Infection Drugs Forecasted Market Size by Type (2026-2031)

5 Gram-positive Bacterial Infection Drugs Breakdown Data by Application

5.1 Global Gram-positive Bacterial Infection Drugs Historic Market Size by Application (2020-2025)

5.2 Global Gram-positive Bacterial Infection Drugs Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Gram-positive Bacterial Infection Drugs Market Size (2020-2031)

6.2 North America Gram-positive Bacterial Infection Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Gram-positive Bacterial Infection Drugs Market Size by Country (2020-2025)

6.4 North America Gram-positive Bacterial Infection Drugs Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Gram-positive Bacterial Infection Drugs Market Size (2020-2031)

7.2 Europe Gram-positive Bacterial Infection Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Gram-positive Bacterial Infection Drugs Market Size by Country (2020-2025)

7.4 Europe Gram-positive Bacterial Infection Drugs Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Gram-positive Bacterial Infection Drugs Market Size (2020-2031)

8.2 Asia-Pacific Gram-positive Bacterial Infection Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Gram-positive Bacterial Infection Drugs Market Size by Region (2020-2025)

8.4 Asia-Pacific Gram-positive Bacterial Infection Drugs Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Gram-positive Bacterial Infection Drugs Market Size (2020-2031)

9.2 Latin America Gram-positive Bacterial Infection Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Gram-positive Bacterial Infection Drugs Market Size by Country (2020-2025)

9.4 Latin America Gram-positive Bacterial Infection Drugs Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Gram-positive Bacterial Infection Drugs Market Size (2020-2031)

10.2 Middle East & Africa Gram-positive Bacterial Infection Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Gram-positive Bacterial Infection Drugs Market Size by Country (2020-2025)

10.4 Middle East & Africa Gram-positive Bacterial Infection Drugs Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Gram-positive Bacterial Infection Drugs Introduction

11.1.4 Pfizer Revenue in Gram-positive Bacterial Infection Drugs Business (2020-2025)

11.1.5 Pfizer Recent Development

11.2 Sanofi

11.2.1 Sanofi Company Details

11.2.2 Sanofi Business Overview

11.2.3 Sanofi Gram-positive Bacterial Infection Drugs Introduction

11.2.4 Sanofi Revenue in Gram-positive Bacterial Infection Drugs Business (2020-2025)

11.2.5 Sanofi Recent Development

11.3 GlaxoSmithKline

11.3.1 GlaxoSmithKline Company Details

11.3.2 GlaxoSmithKline Business Overview

11.3.3 GlaxoSmithKline Gram-positive Bacterial Infection Drugs Introduction

11.3.4 GlaxoSmithKline Revenue in Gram-positive Bacterial Infection Drugs Business (2020-2025)

11.3.5 GlaxoSmithKline Recent Development

11.4 Bayer

11.4.1 Bayer Company Details

11.4.2 Bayer Business Overview

11.4.3 Bayer Gram-positive Bacterial Infection Drugs Introduction

11.4.4 Bayer Revenue in Gram-positive Bacterial Infection Drugs Business (2020-2025)

11.4.5 Bayer Recent Development

11.5 Bristol-Myers Squibb

11.5.1 Bristol-Myers Squibb Company Details

11.5.2 Bristol-Myers Squibb Business Overview

11.5.3 Bristol-Myers Squibb Gram-positive Bacterial Infection Drugs Introduction

11.5.4 Bristol-Myers Squibb Revenue in Gram-positive Bacterial Infection Drugs Business (2020-2025)

11.5.5 Bristol-Myers Squibb Recent Development

11.6 Novartis

11.6.1 Novartis Company Details

11.6.2 Novartis Business Overview

11.6.3 Novartis Gram-positive Bacterial Infection Drugs Introduction

11.6.4 Novartis Revenue in Gram-positive Bacterial Infection Drugs Business (2020-2025)

11.6.5 Novartis Recent Development

11.7 Merck

11.7.1 Merck Company Details

11.7.2 Merck Business Overview

11.7.3 Merck Gram-positive Bacterial Infection Drugs Introduction

11.7.4 Merck Revenue in Gram-positive Bacterial Infection Drugs Business (2020-2025)

11.7.5 Merck Recent Development

11.8 AstraZeneca

11.8.1 AstraZeneca Company Details

11.8.2 AstraZeneca Business Overview

11.8.3 AstraZeneca Gram-positive Bacterial Infection Drugs Introduction

11.8.4 AstraZeneca Revenue in Gram-positive Bacterial Infection Drugs Business (2020-2025)

11.8.5 AstraZeneca Recent Development

11.9 Allergan

11.9.1 Allergan Company Details

11.9.2 Allergan Business Overview

11.9.3 Allergan Gram-positive Bacterial Infection Drugs Introduction

11.9.4 Allergan Revenue in Gram-positive Bacterial Infection Drugs Business (2020-2025)

11.9.5 Allergan Recent Development

11.10 Theravance Biopharma

11.10.1 Theravance Biopharma Company Details

11.10.2 Theravance Biopharma Business Overview

11.10.3 Theravance Biopharma Gram-positive Bacterial Infection Drugs Introduction

11.10.4 Theravance Biopharma Revenue in Gram-positive Bacterial Infection Drugs Business (2020-2025)

11.10.5 Theravance Biopharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Pfizer Inc

Sanofi

GlaxoSmithKline PLC

Bayer

Bristol–Myers Squibb

Novartis

Merck

Astrazeneca plc

Allergan plc

Theravance Biopharma

List of Tables

Table 1. Global Gram-positive Bacterial Infection Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Antibiotic

Table 3. Key Players of Antifungal

Table 4. Key Players of Others

Table 5. Global Gram-positive Bacterial Infection Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Gram-positive Bacterial Infection Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Gram-positive Bacterial Infection Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Gram-positive Bacterial Infection Drugs Market Share by Region (2020-2025)

Table 9. Global Gram-positive Bacterial Infection Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Gram-positive Bacterial Infection Drugs Market Share by Region (2026-2031)

Table 11. Gram-positive Bacterial Infection Drugs Market Trends

Table 12. Gram-positive Bacterial Infection Drugs Market Drivers

Table 13. Gram-positive Bacterial Infection Drugs Market Challenges

Table 14. Gram-positive Bacterial Infection Drugs Market Restraints

Table 15. Global Gram-positive Bacterial Infection Drugs Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Gram-positive Bacterial Infection Drugs Market Share by Players (2020-2025)

Table 17. Global Top Gram-positive Bacterial Infection Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gram-positive Bacterial Infection Drugs as of 2024)

Table 18. Ranking of Global Top Gram-positive Bacterial Infection Drugs Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Gram-positive Bacterial Infection Drugs Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Gram-positive Bacterial Infection Drugs, Headquarters and Area Served

Table 21. Global Key Players of Gram-positive Bacterial Infection Drugs, Product and Application

Table 22. Global Key Players of Gram-positive Bacterial Infection Drugs, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Gram-positive Bacterial Infection Drugs Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Gram-positive Bacterial Infection Drugs Revenue Market Share by Type (2020-2025)

Table 26. Global Gram-positive Bacterial Infection Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Gram-positive Bacterial Infection Drugs Revenue Market Share by Type (2026-2031)

Table 28. Global Gram-positive Bacterial Infection Drugs Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Gram-positive Bacterial Infection Drugs Revenue Market Share by Application (2020-2025)

Table 30. Global Gram-positive Bacterial Infection Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Gram-positive Bacterial Infection Drugs Revenue Market Share by Application (2026-2031)

Table 32. North America Gram-positive Bacterial Infection Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Gram-positive Bacterial Infection Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Gram-positive Bacterial Infection Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Gram-positive Bacterial Infection Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Gram-positive Bacterial Infection Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Gram-positive Bacterial Infection Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Gram-positive Bacterial Infection Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Gram-positive Bacterial Infection Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Gram-positive Bacterial Infection Drugs Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Gram-positive Bacterial Infection Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Gram-positive Bacterial Infection Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Gram-positive Bacterial Infection Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Gram-positive Bacterial Infection Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Gram-positive Bacterial Infection Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Gram-positive Bacterial Infection Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 47. Pfizer Company Details

Table 48. Pfizer Business Overview

Table 49. Pfizer Gram-positive Bacterial Infection Drugs Product

Table 50. Pfizer Revenue in Gram-positive Bacterial Infection Drugs Business (2020-2025) & (US$ Million)

Table 51. Pfizer Recent Development

Table 52. Sanofi Company Details

Table 53. Sanofi Business Overview

Table 54. Sanofi Gram-positive Bacterial Infection Drugs Product

Table 55. Sanofi Revenue in Gram-positive Bacterial Infection Drugs Business (2020-2025) & (US$ Million)

Table 56. Sanofi Recent Development

Table 57. GlaxoSmithKline Company Details

Table 58. GlaxoSmithKline Business Overview

Table 59. GlaxoSmithKline Gram-positive Bacterial Infection Drugs Product

Table 60. GlaxoSmithKline Revenue in Gram-positive Bacterial Infection Drugs Business (2020-2025) & (US$ Million)

Table 61. GlaxoSmithKline Recent Development

Table 62. Bayer Company Details

Table 63. Bayer Business Overview

Table 64. Bayer Gram-positive Bacterial Infection Drugs Product

Table 65. Bayer Revenue in Gram-positive Bacterial Infection Drugs Business (2020-2025) & (US$ Million)

Table 66. Bayer Recent Development

Table 67. Bristol-Myers Squibb Company Details

Table 68. Bristol-Myers Squibb Business Overview

Table 69. Bristol-Myers Squibb Gram-positive Bacterial Infection Drugs Product

Table 70. Bristol-Myers Squibb Revenue in Gram-positive Bacterial Infection Drugs Business (2020-2025) & (US$ Million)

Table 71. Bristol-Myers Squibb Recent Development

Table 72. Novartis Company Details

Table 73. Novartis Business Overview

Table 74. Novartis Gram-positive Bacterial Infection Drugs Product

Table 75. Novartis Revenue in Gram-positive Bacterial Infection Drugs Business (2020-2025) & (US$ Million)

Table 76. Novartis Recent Development

Table 77. Merck Company Details

Table 78. Merck Business Overview

Table 79. Merck Gram-positive Bacterial Infection Drugs Product

Table 80. Merck Revenue in Gram-positive Bacterial Infection Drugs Business (2020-2025) & (US$ Million)

Table 81. Merck Recent Development

Table 82. AstraZeneca Company Details

Table 83. AstraZeneca Business Overview

Table 84. AstraZeneca Gram-positive Bacterial Infection Drugs Product

Table 85. AstraZeneca Revenue in Gram-positive Bacterial Infection Drugs Business (2020-2025) & (US$ Million)

Table 86. AstraZeneca Recent Development

Table 87. Allergan Company Details

Table 88. Allergan Business Overview

Table 89. Allergan Gram-positive Bacterial Infection Drugs Product

Table 90. Allergan Revenue in Gram-positive Bacterial Infection Drugs Business (2020-2025) & (US$ Million)

Table 91. Allergan Recent Development

Table 92. Theravance Biopharma Company Details

Table 93. Theravance Biopharma Business Overview

Table 94. Theravance Biopharma Gram-positive Bacterial Infection Drugs Product

Table 95. Theravance Biopharma Revenue in Gram-positive Bacterial Infection Drugs Business (2020-2025) & (US$ Million)

Table 96. Theravance Biopharma Recent Development

Table 97. Research Programs/Design for This Report

Table 98. Key Data Information from Secondary Sources

Table 99. Key Data Information from Primary Sources

Table 100. Authors List of This Report

List of Figures

Figure 1. Gram-positive Bacterial Infection Drugs Picture

Figure 2. Global Gram-positive Bacterial Infection Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Gram-positive Bacterial Infection Drugs Market Share by Type: 2024 VS 2031

Figure 4. Antibiotic Features

Figure 5. Antifungal Features

Figure 6. Others Features

Figure 7. Global Gram-positive Bacterial Infection Drugs Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Gram-positive Bacterial Infection Drugs Market Share by Application: 2024 VS 2031

Figure 9. Hospital Pharmacies Case Studies

Figure 10. Retail Pharmacies Case Studies

Figure 11. Online Pharmacies Case Studies

Figure 12. Gram-positive Bacterial Infection Drugs Report Years Considered

Figure 13. Global Gram-positive Bacterial Infection Drugs Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Gram-positive Bacterial Infection Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Gram-positive Bacterial Infection Drugs Market Share by Region: 2024 VS 2031

Figure 16. Global Gram-positive Bacterial Infection Drugs Market Share by Players in 2024

Figure 17. Global Top Gram-positive Bacterial Infection Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gram-positive Bacterial Infection Drugs as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Gram-positive Bacterial Infection Drugs Revenue in 2024

Figure 19. North America Gram-positive Bacterial Infection Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Gram-positive Bacterial Infection Drugs Market Share by Country (2020-2031)

Figure 21. United States Gram-positive Bacterial Infection Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Gram-positive Bacterial Infection Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Gram-positive Bacterial Infection Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Gram-positive Bacterial Infection Drugs Market Share by Country (2020-2031)

Figure 25. Germany Gram-positive Bacterial Infection Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Gram-positive Bacterial Infection Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Gram-positive Bacterial Infection Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Gram-positive Bacterial Infection Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Gram-positive Bacterial Infection Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Gram-positive Bacterial Infection Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Gram-positive Bacterial Infection Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Gram-positive Bacterial Infection Drugs Market Share by Region (2020-2031)

Figure 33. China Gram-positive Bacterial Infection Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Gram-positive Bacterial Infection Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Gram-positive Bacterial Infection Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Gram-positive Bacterial Infection Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Gram-positive Bacterial Infection Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Gram-positive Bacterial Infection Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Gram-positive Bacterial Infection Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Gram-positive Bacterial Infection Drugs Market Share by Country (2020-2031)

Figure 41. Mexico Gram-positive Bacterial Infection Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Gram-positive Bacterial Infection Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Gram-positive Bacterial Infection Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Gram-positive Bacterial Infection Drugs Market Share by Country (2020-2031)

Figure 45. Turkey Gram-positive Bacterial Infection Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Gram-positive Bacterial Infection Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Gram-positive Bacterial Infection Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Pfizer Revenue Growth Rate in Gram-positive Bacterial Infection Drugs Business (2020-2025)

Figure 49. Sanofi Revenue Growth Rate in Gram-positive Bacterial Infection Drugs Business (2020-2025)

Figure 50. GlaxoSmithKline Revenue Growth Rate in Gram-positive Bacterial Infection Drugs Business (2020-2025)

Figure 51. Bayer Revenue Growth Rate in Gram-positive Bacterial Infection Drugs Business (2020-2025)

Figure 52. Bristol-Myers Squibb Revenue Growth Rate in Gram-positive Bacterial Infection Drugs Business (2020-2025)

Figure 53. Novartis Revenue Growth Rate in Gram-positive Bacterial Infection Drugs Business (2020-2025)

Figure 54. Merck Revenue Growth Rate in Gram-positive Bacterial Infection Drugs Business (2020-2025)

Figure 55. AstraZeneca Revenue Growth Rate in Gram-positive Bacterial Infection Drugs Business (2020-2025)

Figure 56. Allergan Revenue Growth Rate in Gram-positive Bacterial Infection Drugs Business (2020-2025)

Figure 57. Theravance Biopharma Revenue Growth Rate in Gram-positive Bacterial Infection Drugs Business (2020-2025)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Gram Staining Market Research Report 2024

Global Staphylococcal Infection Drugs Market Insights Forecast to 2030

Global Enterobacteriaceae Infection Drug Market Research Report 2024

Gram Negative lnfections Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Microbial Antibacterial Drugs Market Research Report 2024

Global Eye Infection Drugs Market Insights Forecast to 2030

Global Gram Staining Kit Market Research Report 2025

Global Klebsiella Pneumoniae Infection Drug Market Research Report 2024

Global Bacterial Disease Diagnostics Market Insights Forecast to 2030

Ampicillin Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Antibiotic Resistance Market Insights Forecast to 2030

Global Bacterial Protein Market Research Report 2024

Carbapenem Based Antibiotics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Broad spectrum Antibiotics Market Research Report 2025

Multidrug Resistant Bacteria Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

B Streptococcus GBS Infection Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Human Papillomavirus Infection Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Positive Inotropic Drug Market Research Report 2024

Group B Streptococcus GBS Infection Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions